Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 9, 2024International Journal of Molecular SciencesOpen Access

Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

СПС. В. ПавловаInstitute of Chemical Biology and Fundamental MedicineASA. E. ShulginaInstitute of Cytology and GeneticsSZSuren M. ZakianInstitute of Chemical Biology and Fundamental Medicine

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Павлова et al. (2024) studied this question.

synapsesocial.com/papers/68e5cdb1b6db643587563a73https://doi.org/10.3390/ijms25168695
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genotype-Phenotype Correlation in Hypertrophic Cardiomyopathy: New Variant p.Arg652Lys in MYH72022 · 7 citations
  2. 2Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics2020 · 67 citations
  3. 3CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy2018 · 256 citations
  4. 4Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells2018 · 97 citations
  5. 5Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N2021 · 29 citations